Barbara Salvatore

Barbara Salvatore

Auto-generated profile, based on publicly available information

Barbara Salvatore

Istituto di Biostrutture e Bioimmagini-CNR, 80145 Naples, Italy

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2008 in Journal of Nuclear Medicine
Verified
Journal Article
Closed access
RFRosa Fonti
Rosa Fonti
BSBarbara Salvatore
Barbara Salvatore
Mario QuarantelliMario Quarantelli
Mario Quarantelli
CSCesare Sirignano
Cesare Sirignano
SSSabrina Segreto
Sabrina Segreto
MSMarco Salvatore
Marco Salvatore
New imaging techniques have been introduced to assess the extent and severity of disease in multiple myeloma (MM) patients. The aim of our study was to compare newer imaging modalities-such as (18)F-FDG PET/CT, (99m)Tc-methoxyisobutylisonitrile ((99m)Tc-MIBI) scintigraphy, and MRI-to assess their relative contribution in the evaluation of MM patients at diagnosis. Thirty-three newly diagnosed patients with MM were prospectively studied. Diagnosis and staging were made according to standard criteria. All patients underwent whole-body (18)F-FDG PET/CT, whole-body (99m)Tc-MIBI, and MRI of the spine and pelvis within 10 d, and imaging findings were compared. (18)F-FDG PET/CT was positive in 32 patients (16 focal uptake, 3 diffuse uptake, 13 focal and diffuse uptake), (99m)Tc-MIBI was positive in 30 patients (6 focal, 11 diffuse, 13 focal and diffuse uptake), and MRI of the spine and pelvis was positive in 27 patients (6 focal, 13 diffuse, 8 focal and diffuse uptake). (18)F-FDG PET/CT showed a total of 196 focal lesions (178 in bones and 18 in soft tissues), of which 121 were in districts other than the spine and pelvis, whereas (99m)Tc-MIBI visualized 63 focal lesions (60 in bones and 3 in soft tissues), of which 53 were in districts other than the spine and pelvis. In the spinal and pelvic regions, (18)F-FDG PET/CT detected 75 focal lesions (35 in spine and 40 in pelvis), (99m)Tc-MIBI visualized 10 focal lesions (1 in spine and 9 in pelvis), and MRI detected 51 focal lesions (40 in spine and 11 in pelvis). In whole-body analysis, (18)F-FDG PET/CT performed better than (99m)Tc-MIBI in the detection of focal lesions, whereas (99m)Tc-MIBI was superior in the visualization of diffuse disease. In the spine and pelvis, MRI was comparable to (18)F-FDG PET/CT and (99m)Tc-MIBI in the detection of focal and diffuse disease, respectively. Because myelomatous lesions may often occur out of spinal and pelvic regions, MRI should be reserved to the evaluation of bone marrow involvement of these districts, whereas (18)F-FDG PET/CT can significantly contribute to an accurate whole-body evaluation of MM patients. Finally, whole-body (99m)Tc-MIBI, despite its limited capacity in detecting focal lesions, may be an alternative option when a PET facility is not available.

7 February 2007 in Annals of Hematology
Verified
Journal Article
Closed access
PDF file
LCLucio Catalano
Lucio Catalano
Silvana Del VecchioSilvana Del Vecchio
Silvana Del Vecchio
FPFara Petruzziello
Fara Petruzziello
RFRosa Fonti
Rosa Fonti
BSBarbara Salvatore
Barbara Salvatore
BRBruno Rotoli
Bruno Rotoli

18 September 2010 in Molecular Imaging and Biology
Verified
Journal Article
Closed access
PDF file
Leonardo PaceLeonardo Pace
Leonardo Pace
ENEmanuele Nicolai
Emanuele Nicolai
DDDomenico D’Amico
Domenico D’Amico
FIFrancesco Ibello
Francesco Ibello
AMAnna Maria Della Morte
Anna Maria Della Morte
ASAndrea Soricelli
Andrea Soricelli

1 April 2015 in Clinical Nuclear Medicine
Verified
Journal Article
Closed access
RFRosa Fonti
Rosa Fonti
Leonardo PaceLeonardo Pace
Leonardo Pace
Claudio CerchioneClaudio Cerchione
Claudio Cerchione
LCLucio Catalano
Lucio Catalano
BSBarbara Salvatore
Barbara Salvatore
Silvana Del VecchioSilvana Del Vecchio
Silvana Del Vecchio
The aim of this study was to compare the relative contribution of 18F-FDG PET/CT, 99mTc-MIBI, and MRI in predicting progression-free survival (PFS) and overall survival (OS) in multiple myeloma (MM) patients. Thirty-three newly diagnosed MM patients had been evaluated in a previous study by 18F-FDG PET/CT, 99mTc-MIBI, and spine and pelvis MRI reporting focal lesions and diffuse bone marrow involvement. Twenty-seven patients were then subjected to a mean follow-up period of 58 months, whereas 6 patients were lost. 18F-FDG PET/CT, 99mTc-MIBI, and MRI were positive in 26, 24, and 22 patients, respectively, showing diffuse bone marrow involvement in 12, 21, and 17 patients and a total of 185, 56, and 39 focal lesions, respectively. At follow-up, 18 patients showed complete or partial remission, whereas 9 patients developed progressive disease, 7 of which died of myeloma. Univariate and subsequent multivariate analysis showed that F-FDG PET/CT focal uptake and Tc-MIBI focal and diffuse uptake predicted PFS (P = 0.0006), whereas 18F-FDG PET/CT focal uptake and 99mTc-MIBI focal uptake predicted OS (P = 0.0010). Although MRI diffuse pattern predicted PFS at univariate analysis (P = 0.0376), it was not retained in the model at multivariate analysis. Receiver operating characteristic curve analysis showed that the number of focal lesions best discriminating for PFS and OS prediction was 4 and 11 for 18F-FDG PET/CT and 2 in both cases for 99mTc-MIBI, respectively. By Kaplan-Meier analysis and log-rank testing, PFS and OS at follow-up were significantly better in patients showing a number of focal lesions at F-FDG PET/CT or Tc-MIBI lower than the respective cutoff (P = 0.03, P = 0.004, and P < 0.0001, respectively). Finally, PFS was significantly better in patients showing absent/faint diffuse Tc-MIBI uptake than in those having moderate/intense diffuse uptake (P = 0.0012). 18F-FDG PET/CT and 99mTc-MIBI may be useful in predicting PFS and OS in myeloma patients.

1 February 2015 in Clinical Nuclear Medicine
Verified
Journal Article
Closed access
Leonardo PaceLeonardo Pace
Leonardo Pace
MKMichele Klain
Michele Klain
BSBarbara Salvatore
Barbara Salvatore
ENEmanuele Nicolai
Emanuele Nicolai
EZEmilia Zampella
Emilia Zampella
MSMarco Salvatore
Marco Salvatore
The aim of this study was to evaluate the role of F-FDG PET/CT performed after surgery but before radioiodine therapy in patients with differentiated thyroid cancer.FDG PET/CT was performed off l-thyroxine in 60 newly diagnosed differentiated thyroid cancer patients. Clinical and hematological evaluation as well as high-resolution neck ultrasound were performed. All patients underwent a complete follow-up (range, 6-67 months; mean [SD], 31.7 [20.6] months). The date of recurrence or the most recent office visit was recorded. Progression-free survival (PFS) is the primary end point of this study. Analysis was performed by Cox proportional hazards model. Survival curves were generated using Kaplan-Meier estimates, and the log-rank test was used to assess significance.FDG PET/CT was negative in 63% of patients, 20% had FDG thyroid bed uptake, 5% distant metastases, and 12% lymph node FDG uptake. In patients with positive FDG PET/CT scan (ie, those with distant metastases or lymph node uptake), a higher rate of recurrence was observed (50% vs 6%, P < 0.05). Thyroglobulin, neck ultrasound, stage, and FDG PET/CT correlated with PFS at univariate analysis. At multivariate analysis, only thyroglobulin and FDG PET/CT continued to be predictors of PFS. Patients with a negative FDG PET/CT scan have a better PFS either in the whole group or in those with elevated thyroglobulin level (both >2 ng/mL and >10 ng/mL).FDG PET/CT was abnormal in 17% of patients. Moreover, FDG PET/CT has an independent prognostic role, with a better PFS in patients with a negative scan.

11 May 2007 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
PMPier Paolo Mainenti
Pier Paolo Mainenti
BSBarbara Salvatore
Barbara Salvatore
DDDario D’antonio
Dario D’antonio
TFTeresa De Falco
Teresa De Falco
GPGiovanni Domenico De Palma
Giovanni Domenico De Palma
MSMarco Salvatore
Marco Salvatore